M. Oh

776 total citations
8 papers, 615 citations indexed

About

M. Oh is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, M. Oh has authored 8 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Genetics and 1 paper in Pathology and Forensic Medicine. Recurrent topics in M. Oh's work include Hemophilia Treatment and Research (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). M. Oh is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). M. Oh collaborates with scholars based in United States, United Kingdom and Sweden. M. Oh's co-authors include Bruce M. Ewenstein, Kathelijn Fischer, Victor S. Blanchette, Gerald Spotts, S. Fritsch, P Schroth, P. Collins, Peter W. Collins, Sven Björkman and Jan Astermark and has published in prestigious journals such as Journal of Thrombosis and Haemostasis, Journal of the American Medical Directors Association and Haemophilia.

In The Last Decade

M. Oh

8 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Oh United States	6	592	174	60	18	15	8	615
Claude Négrier France	13	569 1.0×	176 1.0×	67 1.1×	20 1.1×	28 1.9×	29	607
Nives Selak Bienz Switzerland	7	516 0.9×	157 0.9×	35 0.6×	11 0.6×	23 1.5×	10	536
Behnaz Pezeshkpoor Germany	12	298 0.5×	65 0.4×	154 2.6×	19 1.1×	12 0.8×	39	357
Marianne Uguen Switzerland	7	373 0.6×	154 0.9×	45 0.8×	5 0.3×	15 1.0×	15	420
F. Abdul Karim Denmark	6	350 0.6×	93 0.5×	53 0.9×	8 0.4×	15 1.0×	10	369
G. Auerswald Germany	10	376 0.6×	121 0.7×	35 0.6×	11 0.6×	5 0.3×	14	397
L. Rusen United States	10	723 1.2×	187 1.1×	93 1.6×	12 0.7×	21 1.4×	20	742
Scharrer Germany	3	288 0.5×	64 0.4×	47 0.8×	7 0.4×	8 0.5×	3	306
Pencho Georgiev Bulgaria	11	230 0.4×	127 0.7×	97 1.6×	13 0.7×	33 2.2×	30	333
Bartlomiej Getta United States	6	184 0.3×	117 0.7×	64 1.1×	4 0.2×	31 2.1×	19	236

Countries citing papers authored by M. Oh

Since Specialization

Citations

This map shows the geographic impact of M. Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Oh more than expected).

Fields of papers citing papers by M. Oh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Oh. The network helps show where M. Oh may publish in the future.

Co-authorship network of co-authors of M. Oh

This figure shows the co-authorship network connecting the top 25 collaborators of M. Oh. A scholar is included among the top collaborators of M. Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Oh. M. Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Oh, M., et al.. (2023). Combinations of Sarcopenia Diagnostic Criteria by Asian Working Group of Sarcopenia (AWGS) 2019 Guideline and Incident Adverse Health Outcomes in Community-Dwelling Older Adults. Journal of the American Medical Directors Association. 24(8). 1185–1192. 5 indexed citations

Valentino, Leonard A., Steven W. Pipe, P. Collins, et al.. (2016). Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic‐guided prophylaxis. Haemophilia. 22(4). 514–520. 55 indexed citations

Stasyshyn, Oleksandra, L. Rusen, M. Şerban, et al.. (2014). Safe switching from a pdFIX (Immunine^®) to a rFIX (Bax326). Haemophilia. 20(5). 674–681. 6 indexed citations

Fischer, Kathelijn, Peter W. Collins, Sven Björkman, et al.. (2011). Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials. Haemophilia. 17(3). 433–438. 36 indexed citations

Björkman, Sven, Victor S. Blanchette, Kathelijn Fischer, et al.. (2010). Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring. Journal of Thrombosis and Haemostasis. 8(4). 730–736. 99 indexed citations

Weng, Hsu‐Huei, Veena K. Ranganath, M. Oh, et al.. (2010). Differences in presentation of younger and older systemic sclerosis patients in clinical trials.. PubMed. 28(5 Suppl 62). S10–4. 5 indexed citations

Collins, Peter W., Sven Björkman, Kathelijn Fischer, et al.. (2009). Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. Journal of Thrombosis and Haemostasis. 8(2). 269–275. 147 indexed citations

Collins, P., Victor S. Blanchette, Kathelijn Fischer, et al.. (2008). Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. Journal of Thrombosis and Haemostasis. 7(3). 413–420. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact